HALEY MCCULLOUGH: Open Payments
NPI 1609331479 · DELTA, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$306 in 16 payments from 9 companies in 2025. Trend: 2023 $196 · 2024 $305 · 2025 $306
Food & beverage: $306
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 5 | $91 |
| Lilly USA, LLC | 3 | $54 |
| AstraZeneca Pharmaceuticals LP | 2 | $42 |
| PFIZER INC. | 1 | $22 |
| Astellas Pharma US Inc | 1 | $22 |
| Novo Nordisk Inc | 1 | $20 |
| Otsuka America Pharmaceutical, Inc. | 1 | $20 |
| Exact Sciences Corporation | 1 | $17 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $16 |
Products named: QULIPTA, MOUNJARO, AIRSUPRA, NURTEC ODT, Veozah, Wegovy, REXULTI, ZEPBOUND.
Industry payments across CO — which companies pay providers there.
